As fundamentals-focused long-term investors, Fools never base an investment decision on the daily gyrations of the market. But the market's daily price movements can be useful when looking for new stock ideas for further research, or to keep tabs on watch-list stocks.

Below you'll find today's biggest movers among our five-star stocks -- the highest rating awarded by our CAPS community of more than 140,000 investors. Have a look, and then visit us on CAPS to dig in further on each of them.


Up Today


Sector Past 30 Days

Fools Saying Outperform


ShengdaTech, Inc.





1307 of 1322


China Medical Technologies, Inc. (ADR)



Health-Care Equipment and Supplies


1396 of 1430


Coca-Cola FEMSA, S.A.B. de C.V. (ADR)





349 of 356


Other Five-Star Chemicals
Innophos Holdings, Inc. (NASDAQ:IPHS) up 1.72%
Olin Corp (NYSE:OLN) up 1.41%
Other Five-Star Health-Care Equipment and Supplies
Syneron Medical Ltd. (NASDAQ:ELOS) up 7.38%
Meridian Bioscience, Inc. (NASDAQ:VIVO) up 2.33%
Other Five-Star Beverages
Coca-Cola HBC S.A. (ADR) (NYSE:CCH) up 2.68%
Compania Cervecerias Unidas S.A. (ADR) (NYSE:CCU) up 1.89%

Come join us on CAPS to learn more about these and countless other interesting stock ideas. Click here for a free sign-up.

Disclosure is important to us here at The Motley Fool. The stocks mentioned in this article received "five-star" ratings from participants in The Motley Fool's CAPS service and are showing strong percentage gains in today's market, at least compared with other CAPS five-star stocks.

No individual person selected the stocks in this article, so there is no author to disclose an interest in them. Since this article was automatically generated by identifying the stocks loved both by the CAPS community and by buyers in today’s market, it is possible that Motley Fool personnel (and even The Motley Fool itself, through our Million Dollar Portfolio, Motley Fool Pro, and Ready Made Millionaire services), have positions in these stocks. We thought you'd like to know that. You can learn more about The Motley Fool’s disclosure policy here.